DCs, the essential population for naive T lymphocyte activation, can acquire tolerogenic phenotype due to signals from tumor cells, but also from binding, via CD80 or CD86, to cytotoxic T lymphocyte-associated protein 4 (CTLA-4) expressed by Treg. Here, CTLA4 is linked to neoplasm.